Tim Van Hauwermeiren co-founded argenx and has served as Chief Executive Officer since April 2008 until May 2026. He has been a member of the Board of Directors since July 2014 and serves as the Chairman of the Board since May 2026.

Tim has more than 20 years of general management and business development experience across the life sciences and consumer goods sectors, including at Ablynx and Procter & Gamble. He holds a B.Sc. and M.Sc. in bioengineering from Ghent University and an Executive MBA from The Vlerick School of Management. 

Tim also serves on the Board of Directors of Lexeo Therapeutics, Inc.